CSPC Group (01093.HK): The trustee purchased 4.79 million shares under the share incentive plan

Gelonghui, April 26, 丨 Shiyao Group (01093.HK) announced that on April 26, 2024, the plan trustee (“trustee”) purchased a total of 4.79 million shares of the company on the market in accordance with the terms and conditions of the plan and held such shares in trust for the benefit of the selected participants.

Gelonghui FinanceApr 26 05:35 ET

藥明康德：2023年度報告

Futu NewsApr 26 04:45 ET · Announcements

On April 26, Yao Ming Kangde (02359.HK) spent 2005 million yuan to buy back 475,500 A shares

Gelonghui, April 26, 丨 Yao Ming Kangde (02359.HK) issued an announcement. On April 26, 2024, it spent RMB 2005 million yuan to buy back 475,500 A shares, with a repurchase price of 41.32-43.11 yuan per share.

Gelonghui FinanceApr 26 04:43 ET

Yao Ming Kangde (02359) spent 2.047,800 yuan to buy back 475,500 A shares on April 26

Yao Ming Kangde (02359) announced that on April 26, 2024, the company spent 2.047,800 yuan to buy back 475,500 A-shares.

Zhitong FinanceApr 26 04:42 ET

CSPC Group (01093.HK): Highly selective MAT2A inhibitor (SYH2039) approved for clinical trials in the US

Gelonghui, April 26, 丨 Shiyao Group (01093.HK) announced that the Class 1 new chemical highly selective MAT2A inhibitor (SYH2039) developed by the Group has been approved by the US Food and Drug Administration (FDA) and can conduct clinical trials in the US. Previously, the product was approved by China's National Drug Administration in March 2024, and clinical trials can be carried out in China. SYH2039 is a highly active methionine adenoganase 2A (MAT2A) inhibitor that selectively kills MTAP-deficient tumor cells and has little effect on normal cells

Gelonghui FinanceApr 26 04:35 ET

Trending Industry Today: TIGERMED Leads Gains In Pharmaceutical Outsourcing/contract Research Organization(cro Concept) Stocks

April 26th - The industry of $Pharmaceutical Outsourcing/contract Research Organization(cro Concept)(BK1261.HK)$ is trending higher today with 8 constituents up and TIGERMED leading Gains.$TIGERMED(03

moomoo NewsApr 26 03:50 ET